Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in Italy
2022-06-23 23:00
FIM World Supercross Championship Unveils New Logo in Global Brand Identity Reveal
2022-06-23 22:30
Process Intelligence and Automation Success Honoured with 2022 Nintex Solution Innovation Awards
2022-06-23 07:23
NEW CAMPAIGN CELEBRATES PREMIUM AUSTRALIAN LEATHER
2022-06-22 18:00
Trajan to acquire leading chromatography consumables and tools business building critical mass in the gas chromatography portfolio
2022-06-19 22:15
ENGINE in the US, Europe, and Australia Rebrands to Big Village, Pioneering the Future of Global Advertising, Technology, Insights and Data
2022-06-18 07:00
US FDA AWARDS ORPHAN DRUG DESIGNATION (ODD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER
2022-06-17 20:00
Bechtel launches second round of STEM Returners program
2022-06-17 10:05
LiveHire and Enboarder Announce Partnership to Deliver Next-Generation Onboarding Experience
2022-06-16 01:00
LexisNexis Risk Solutions Study Estimates Australian Financial Services Firms Will Spend More Than U.S. $2.54 Billion on Financial Crime Compliance in 2022
2022-06-15 08:00
Telix and Invicro Advance AI Partnership
2022-06-14 19:00
TradeWindow Standardises on Nintex Promapp to Support Global Growth
2022-06-14 07:17
Jubilant Radiopharma Joins Illuccix® Pharmacy Partner Network
2022-06-13 19:11
Novavax COVID-19 Vaccine Nuvaxovid™ Provisionally Registered in Australia as a Booster in Individuals Aged 18 and Over
2022-06-13 19:00
POSITIVE DATA FOR PAXALISIB IN TWO CHILDHOOD BRAIN CANCERS PRESENTED AT 20TH ISPNO ANNUAL MEETING
2022-06-13 19:00
Telix and RefleXion Expand Partnership for Prostate Cancer Treatment
2022-06-10 19:00
RAD adds brain tumor technology to portfolio
2022-06-10 10:21
World leading organisations support IAF's global certificate database
2022-06-09 23:00
Techtronic Industries Australia selects One Network Enterprises to Enhance Supplier Collaboration for Improved Demand and Supply Planning
2022-06-07 21:00
Telix to Present at Jefferies Healthcare Conference
2022-06-07 19:00
1
16
17
18
19
20
113